BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants

  SAB Biotherapeutics today announced the publication of data showing that SAB-185, the company’s therapeutic candidate for the treatment of COVID-19 infections, demonstrates effective and potent neutralization of multiple SARS-CoV-2 variants of concern, including the Delta and Lambda variants.

  August 11, 2021

   · 

  8 min read
• Business

  Gamida Cell Reports Second Quarter 2021 Financial Results and Provides Company Update

  Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today reported financial results for the quarter ended June 30, 2021.

  August 11, 2021

   · 

  18 min read
• Cytocom, Inc. Announces Participation at Liberty University’s Empowering the Kingdom Through Business Conference

  Cytocom, Inc. today announced that the company will participate at the Empowering the Kingdom through Business Conference hosted by the Liberty University School of Business on August 10-12, 2021.

  August 11, 2021

   · 

  5 min read
• Business

  Evogene Reports Second Quarter 2021 Financial Results

  - Evogene’s management provides update on its plans for unlocking the value of its subsidiaries - Conference call and webcast: today, August 11, 2021, 9:00 am ET

  August 11, 2021

   · 

  16 min read
• Business

  Diffusion Pharmaceuticals Reports Q2 Financial Results and Provides Business Update

  Diffusion Pharmaceuticals Inc. today announced financial results for the second quarter of 2021 and provided a business update.

  August 11, 2021

   · 

  8 min read
• Virios Therapeutics to Present at the SNN Network Summer Virtual Conference

  Virios Therapeutics, Inc. announced today that Greg Duncan, Chairman and Chief Executive Officer, will present a company overview at the SNN Network Summer Virtual Conference on August 19, 2021 at 9:00 a.m. ET.

  August 11, 2021

   · 

  3 min read